BE1000732A5 - Compositions pharmaceutiques a liberation prolongee. - Google Patents

Compositions pharmaceutiques a liberation prolongee. Download PDF

Info

Publication number
BE1000732A5
BE1000732A5 BE8701131A BE8701131A BE1000732A5 BE 1000732 A5 BE1000732 A5 BE 1000732A5 BE 8701131 A BE8701131 A BE 8701131A BE 8701131 A BE8701131 A BE 8701131A BE 1000732 A5 BE1000732 A5 BE 1000732A5
Authority
BE
Belgium
Prior art keywords
sep
pharmaceutical composition
composition according
acetylsalicylic acid
approximately
Prior art date
Application number
BE8701131A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1000732A5 publication Critical patent/BE1000732A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE8701131A 1986-10-09 1987-10-02 Compositions pharmaceutiques a liberation prolongee. BE1000732A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE1000732A5 true BE1000732A5 (fr) 1989-03-21

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8701131A BE1000732A5 (fr) 1986-10-09 1987-10-02 Compositions pharmaceutiques a liberation prolongee.

Country Status (24)

Country Link
JP (1) JPS63101334A (it)
KR (1) KR880004801A (it)
AU (1) AU7942087A (it)
BE (1) BE1000732A5 (it)
CA (1) CA1332809C (it)
CH (1) CH675831A5 (it)
DE (1) DE3733540A1 (it)
DK (1) DK527487A (it)
ES (1) ES2014518A6 (it)
FI (1) FI874414A (it)
FR (1) FR2604902B1 (it)
GB (2) GB8624213D0 (it)
GR (1) GR871550B (it)
HU (1) HU201875B (it)
IL (1) IL84104A0 (it)
IT (1) IT1221493B (it)
LU (1) LU87009A1 (it)
NL (1) NL8702294A (it)
NO (1) NO874200L (it)
NZ (1) NZ222083A (it)
PH (1) PH24227A (it)
PT (1) PT85880B (it)
SE (1) SE8703889L (it)
ZA (1) ZA877617B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
HU230440B1 (hu) 1999-03-31 2016-06-28 Janssen Pharmaceutica N.V Előgélesített keményítőt tartalmazó szabályozott felszabadulású készítmények
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
JP4814885B2 (ja) * 2004-09-09 2011-11-16 サイコファルマ，エッセ．エ．デ セ．ウヴェ． ヒドララジン持続放出用医薬組成物および該組成物を含む癌治療薬

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758679A (en) * 1972-02-22 1973-09-11 Lilly Co Eli Propoxyphene napsylate timed release particles
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
EP0146863A2 (de) * 1983-12-23 1985-07-03 Bayer Ag Orale retardierte Acetylsalicylsäureformulierungen
EP0156592A2 (en) * 1984-03-21 1985-10-02 American Home Products Corporation Substained release pharmaceutical capsules

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758679A (en) * 1972-02-22 1973-09-11 Lilly Co Eli Propoxyphene napsylate timed release particles
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4389393B1 (it) * 1982-03-26 1985-10-22
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
EP0146863A2 (de) * 1983-12-23 1985-07-03 Bayer Ag Orale retardierte Acetylsalicylsäureformulierungen
EP0156592A2 (en) * 1984-03-21 1985-10-02 American Home Products Corporation Substained release pharmaceutical capsules

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIE PHARMAZIE, vol. 33, no. 11, 1978, pages 747-749, VEB Verlag Volk und Gesundheit, Berlin, DE; G. NAGY et al.: "Untersuchungen }ber die Textur und die Eigenschaften von Acetylsalicyls{ure-Tabletten" *

Also Published As

Publication number Publication date
GB2195893B (en) 1991-05-08
DK527487D0 (da) 1987-10-08
FR2604902A1 (fr) 1988-04-15
PT85880B (pt) 1990-07-31
DK527487A (da) 1988-04-10
GR871550B (en) 1988-02-15
GB2195893A (en) 1988-04-20
HU201875B (en) 1991-01-28
AU7942087A (en) 1988-04-14
CA1332809C (en) 1994-11-01
GB8624213D0 (en) 1986-11-12
ES2014518A6 (es) 1990-07-16
GB8723515D0 (en) 1987-11-11
IT8748469A0 (it) 1987-10-08
SE8703889L (sv) 1988-04-10
KR880004801A (ko) 1988-06-27
JPS63101334A (ja) 1988-05-06
NL8702294A (nl) 1988-05-02
PH24227A (en) 1990-05-04
SE8703889D0 (sv) 1987-10-08
CH675831A5 (it) 1990-11-15
DE3733540A1 (de) 1988-04-14
ZA877617B (en) 1989-05-30
FR2604902B1 (fr) 1991-04-26
LU87009A1 (fr) 1988-05-03
IT1221493B (it) 1990-07-06
HUT52958A (en) 1990-09-28
NO874200L (no) 1988-04-11
FI874414A0 (fi) 1987-10-07
FI874414A (fi) 1988-04-10
PT85880A (en) 1987-11-01
NO874200D0 (no) 1987-10-07
IL84104A0 (en) 1988-03-31
NZ222083A (en) 1991-05-28

Similar Documents

Publication Publication Date Title
JP5658172B2 (ja) アムロジピン及びロサルタンを含む固形薬剤学的組成物及びその製造方法
BE1011045A3 (fr) Compositions pharmaceutiques pour la liberation controlee de substances actives.
BE1012733A6 (fr) Formulations pharmaceutiques nouvelles comprenant l'amoxycilline et du clavulanate de potassium.
EP2605757B1 (fr) Formulations a base de nalbuphine et leurs utilisations
NO333936B1 (no) Oralt farmasøytisk preparat som inneholder minst to separate formuleringer
BE1000732A5 (fr) Compositions pharmaceutiques a liberation prolongee.
BE1000661A4 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene.
CA2287800C (fr) Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellulose a titre d'agents desintegrants, et procede d'obtention
HRP20010277A2 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
CA2577361C (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
FR2930147A1 (fr) Forme orale solide dotee d'un double profil de liberation
US20210369621A1 (en) Pregabalin sustained release composition and method for preparing the same
JP2002522377A (ja) イブプロフェンおよびドンペリドンを含んで成る製薬組成物
BE1010972A6 (fr) Composition pharmaceutique antituberculeuse et procede destine a produire ladite composition.
RU2698703C2 (ru) Твердая фармацевтическая композиция, содержащая амлодипин и лозартан
FR2509174A1 (fr) Composition anti-acide a base de n-acetyl-p-aminophenol
EP2802311A1 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
EP1465607B1 (fr) Compositions pharmaceutiques a liberation modifiee
CA2611125A1 (fr) Formulation a liberation prolongee de principes actifs de medicaments
TW200826962A (en) Oral solid composition masking bitterness
CN113747885B (zh) 包含依泽替米贝和氯沙坦的药物组合制剂
TW201006826A (en) Method of treatment using eprosartan
JP2002532538A (ja) プロフェンを含有する医薬混合物
JP2004010611A (ja) マスキング組成物
EP0975337A2 (en) Fast release compressed tablet of flurbiprofen

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: S.A. SANDOZ

Effective date: 19911031